PREVALUNG EU | Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception.
01-12-2022
-30-11-2027
01-12-2022
-30-11-2027
01-01-2015
-31-12-2018
01-02-2015
-31-01-2019
01-01-2017
-31-12-2020
01-10-2016
-30-09-2020
01-01-2017
-30-06-2021
01-05-2019
-30-04-2023
01-10-2024
-30-09-2028
01-11-2017
-30-04-2021
01-12-2018
-31-05-2022
01-04-2023
-31-03-2028
01-01-2024
-31-12-2029
01-01-2021
-31-12-2024
01-05-2017
-31-10-2021
01-01-2016
-31-12-2021
01-01-2016
-31-12-2019
01-04-2024
-30-09-2028
01-05-2021
-30-04-2026
01-12-2023
-30-11-2027
01-05-2020
-30-04-2024
01-11-2019
-30-04-2024
01-06-2017
-30-11-2022
01-01-2019
-30-06-2024
01-01-2020
-31-12-2024
01-01-2016
-31-12-2019
01-01-2018
-30-06-2023
01-05-2015
-31-10-2020
01-06-2015
-31-05-2019
01-11-2019
-29-02-2024
01-12-2016
-30-11-2020